JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Support: [email protected]

Track Your Order

Tyrosine Kinase

A5760 KRN 633

Summary: VEGFR inhibitor,ATP-competitive

insoluble in EtOH; insoluble in H2O; ≥13.75 mg/mL
B8003 WH-4-023

Summary: Lck/Src inhibitor,potent and selective

≥56.9 mg/mL
B6193 AMG 337

Summary: MET inhibitor

≥46.3 mg/mL
C5737 JNJ-10198409

Summary: inhibitor of platelet-derived growth factor (PDGF-BB) tyrosine kinase

≤10 mg/mL
A5467 Ponatinib (AP24534)
1 Citation

Target: VEGFR|PDGFR|Bcr-Abl|FGFR|Src

Summary: pan-BCR-ABL inhibitor,multi-kinase inhibitor

≥53.3 mg/mL
B6006 NPS-1034

Summary: MET inhibitor

Soluble in DMSO
C5465 AG-1295

Summary: potent and selective inhibitor of PDGF receptor kinase

≥7.73 mg/mL
B7452 Src I1

Summary: competitive dual site (ATP- and peptide-binding) Src kinase inhibitor

Soluble in DMSO
A8199 PD153035 hydrochloride
1 Citation

Target: EGFR

Summary: Potent EGFR inhibitor

insoluble in EtOH; insoluble in H2O; ≥3.97 mg/mL
A5331 TSU-68 (SU6668,Orantinib)

Summary: PDGFR/Flk-1/FGFR1 inhibitor,potent and competitive

insoluble in EtOH; insoluble in H2O; ≥15.5 mg/mL